2011 Annual Meeting | Myelopathies

Date Saturday 04/16/11

Time 09:00 AM - 01:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Neeraj Kumar, MD

Topic(s)

Learning Objectives Participants should be able to confidently diagnose the wide spectrum of disorders of the spinal cord and have a practical approach toward the work-up and management of these patients; be aware of the recent advances in conditions like neuromyelitis optica, copper deficiency myelopathy, hereditary spastic paraplegia, myelopathies related to spinal dural arteriovenous fistulas, and paraneoplastic myelopathies; and know the recommendations regarding use of steroids in compressive myelopathies.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist

Teaching Styles Case-based, Didactic

Event Timeline
09:00 AM - 09:50 AM		Spinal Cord Syndromes and Vascular Myelopathies Jose Biller, MD, FACP, FAHA, FAAN
09:50 AM - 10:40 AM		Inflammatory and Infectious Myelopathies Dean M. Wingerchuk, MD, FAAN
10:40 AM - 11:00 AM		Break
11:00 AM - 11:50 AM		Metabolic and Hereditary Myelopathies Neeraj Kumar, MD
11:50 AM - 12:40 AM		Neoplastic and Other Compressive Myelopathies Julie E. Hammack, MD, FAAN
12:40 PM - 01:00 PM		Panel Discussion

Faculty Disclosures
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Neeraj Kumar, MD	Dr. Kumar has nothing to disclose.
Julie E. Hammack, MD, FAAN	Dr. Hammack has nothing to disclose.

��ɫ��

��ɫ��